4DMedical Ltd
ASX:4DX

Watchlist Manager
4DMedical Ltd Logo
4DMedical Ltd
ASX:4DX
Watchlist
Price: 1.785 AUD -5.05%
Market Cap: 873.5m AUD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

4DX Price Targets Summary
4DMedical Ltd

Wall Street analysts forecast 4DX stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 4DX is 0.755 AUD with a low forecast of 0.737 AUD and a high forecast of 0.788 AUD.

4DX Lowest Forecast
Wall Street Target
0.737 AUD
59% Downside
4DX Average Forecast
Wall Street Target
0.755 AUD
58% Downside
4DX Highest Forecast
Wall Street Target
0.788 AUD
56% Downside
Lowest
Price Target
0.737 AUD
59% Downside
Average
Price Target
0.755 AUD
58% Downside
Highest
Price Target
0.788 AUD
56% Downside
4DMedical Ltd Competitors:
Price Targets
CRW
Craneware PLC
16% Upside
ALC
Alcidion Group Ltd
22% Upside
GPI
GPI SpA
5% Downside
W
WAY
Waystar Holding Corp
31% Upside
CRW
Craneware PLC
16% Upside
ALC
Alcidion Group Ltd
22% Upside
GPI
GPI SpA
5% Downside
W
WAY
Waystar Holding Corp
31% Upside
A
AIFORIA
Aiforia Technologies Oyj
65% Upside
4480
Medley Inc
73% Upside
300451
B-SOFT Co Ltd
35% Upside
SLP
Simulations Plus Inc
63% Upside

Revenue
Forecast

Revenue Estimate
4DMedical Ltd

For the last 7 years the compound annual growth rate for 4DMedical Ltd's revenue is 33%. The projected CAGR for the next 3 years is 90%.

33%
Past Growth
90%
Estimated Growth
Estimates Accuracy
-43%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
4DMedical Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
24%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
4DMedical Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-14%
Average Miss
What are analyst estimates?

See Also

Summary
4DX intrinsic value, competitors valuation, and company profile.
DCF Valuation
4DX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
4DX stock valuation using valuation multiples.
Wall Street Estimates
4DX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
4DX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is 4DX's stock price target?
Price Target
0.755 AUD

According to Wall Street analysts, the average 1-year price target for 4DX is 0.755 AUD with a low forecast of 0.737 AUD and a high forecast of 0.788 AUD.

What is 4DMedical Ltd's Revenue forecast?
Projected CAGR
90%

For the last 7 years the compound annual growth rate for 4DMedical Ltd's revenue is 33%. The projected CAGR for the next 3 years is 90%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 283,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.